GAK and chordoma: EGFR inhibitors, identified as a potential therapeutic target for chordoma by screening 1097 focused libraries of compounds [17], and specific inhibitors that target EGFR and cyclin G-associated kinase (GAK) showed efficacy in chordoma cells [18].